Nu Skin ( NUS ) is a potential turnaround stock, but its turnaround might not be complete in 2026. This MLM sells skincare products, and like other MLMs, its market has been shrinking. As a result, Nu Skin is trading at veryI am a freelance business writer. I formerly wrote articles for the Motley Fool Blogging Network, where I won several editor's choice awards. After that, I wrote articles for the main Motley Fool site. I typically focus on restaurants, retailers, and food manufacturers, considering both ...

Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities reported modest gains in the fourth quarter of 2025. The quarter started as a continuation of the post-Liberation Day risk-on market environment, while it ended on a strong note, driven by a positive macroeconomic backdrop. Attractive valuations, earnings recovery, broadening of the market, and a shift from mega-ca ...

Core Insights - Nu Skin Enterprises, Inc. (NUS) reported fourth-quarter 2025 results that fell short of Zacks Consensus Estimates, with both earnings and net sales declining year over year [1][10]. Financial Performance - Adjusted earnings for the fourth quarter were 29 cents per share, down from 38 cents per share in the same quarter last year, missing the consensus estimate of 30 cents [1][10]. - Quarterly revenues totaled $370.3 million, a decline of 16.9% year over year, with a negative impact of 0.2% from foreign currency fluctuations. On a constant-currency basis, revenues fell 16.7% [2][10]. - Adjusted gross profit was $262 million, down 17.6% from $317.9 million in the prior year, with an adjusted gross margin of 70.7%, a decrease of 70 basis points from the previous year [3][5]. - Selling expenses decreased by 20.6% to $131.3 million, representing 35.5% of revenues, down 160 basis points from the prior year [4][5]. - General and administrative expenses were $107.4 million, down 11.2% year over year, but as a percentage of revenues, they increased to 29% [5]. Customer and Sales Metrics - Sales leaders decreased by 19% year over year to 30,045, while the customer base dropped by 10% to 748,796. Paid affiliates also fell by 11% to 129,311 [2][10]. - Region-wise revenue declines were noted across various markets, with the Americas down 9.8% and Southeast Asia/Pacific down 22.7% [6]. Future Guidance - For 2026, Nu Skin anticipates revenues between $1.35 billion and $1.50 billion, indicating a potential decline of 9% to 1% from the previous year, with EPS expected to be between 80 cents and $1.20 [11][10]. - The first quarter of 2026 is projected to see revenues between $320 million and $340 million, reflecting a decline of 7-12% [12]. Financial Health - At the end of the quarter, the company had cash and cash equivalents of $238.6 million, long-term debt of $204.2 million, and total stockholders' equity of $805.2 million [7]. - The company declared a cash dividend of 6 cents per share, payable on March 11, 2026 [8].

Core Insights - NU Skin Enterprises Inc. reported revenue of $370.3 million, adjusted net income of $14.5 million, and adjusted EPS of $0.29, which were below estimates of $380.2 million, $15.1 million, and $0.30 respectively, indicating weaker-than-expected top-line results [1] - The results were at the low end of revenue guidance and the high end of EPS guidance, with a gross margin of 77.6% for the Nu Skin business [1] - Management emphasized strategic penetration into India and other emerging markets, along with margin expansion and a one-time tax benefit, as key contributors to the EPS results for FY25 [1] Financial Performance - Revenue from Rhyz was $48.52 million, comprising $42.45 million from Manufacturing and $6.07 million from Rhyz Other [1] - Selling expenses for the core business decreased to 40.8%, reflecting disciplined spending [1] Strategic Initiatives - Management remains focused on executing strategic initiatives despite the weaker top-line results [1] - The rollout of Prism iO is advancing with a pre-launch in India underway, and a full opening expected in the second half of FY26 [7] - FY26 EPS guidance is set at a midpoint of $1.00 [7]

Core Insights - The consumer staples sector has identified oversold stocks, presenting potential investment opportunities in undervalued companies [1] - The Relative Strength Index (RSI) is a key momentum indicator used to assess stock performance, with an RSI below 30 indicating that a stock is considered oversold [1] Oversold Stocks List - Notable companies with an RSI near or below 30 include NU Skin Enterprises Inc (NYSE:NUS), Coty Inc (NYSE:COTY), and Honest Company Inc (NASDAQ:HNST) [2][3]

Napierski positioned Prysm iO as a central part of the company’s move into the “wellness revolution,” describing it as a non-invasive carotenoid measurement device designed to provide insights across four domains: diet, fitness, lifestyle, and nutritional supplementation. He said Nu Skin is building on its portfolio of connected devices and its BioPhotonic Scanner technology.Napierski described “switching costs” tied to changes in business practices during 2025 and into early 2026, but said the company beli ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-12421 NU SKIN ENTERPRISES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.33%. A quarter ago, it was expected that this seller of skin care and nutritional products through a direct-selling model would post earnings of $0.3 per share when it actually produced earnings of $0.34, deli ...

Nu Skin Enterprises (NYSE:NUS) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsB.G. Hunt - VP of Treasurer and Investor RelationsDave Storms - Director of Equity ResearchJames Thomas - CFORyan Napierski - President and CEOOperatorGood day, and thank you for standing by. Welcome to the Q4 2025 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question, please press star one ...

Nu Skin Enterprises (NYSE:NUS) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsB.G. Hunt - VP of Treasurer and Investor RelationsDave Storms - Director of Equity ResearchJames Thomas - CFORyan Napierski - President and CEOOperatorGood day, and thank you for standing by. Welcome to the Q4 2025 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question, please press star one ...